Well-differentiated neuroendocrine tumors of the kidney: Clinical characterics and treatment outcomes of a very rare disease

被引：0
|
作者：
Apostolidis, L. [1 ]
Kreutzfeldt, S. [2 ,3 ]
Winkler, E. C. [1 ]
Kratochwil, C. [4 ]
Kender, Z. [5 ]
机构：
[1] Heidelberg Univ Hosp, Natl Ctr Tumor Dis NCT Heidelberg, Dept Med Oncol, Heidelberg, Germany
[2] Natl Ctr Tumor Dis NCT Heidelberg, Dept Translat Med Oncol, Heidelberg, Germany
[3] German Canc Res Ctr, Heidelberg, Germany
[4] Heidelberg Univ Hosp, Dept Nucl Med, Heidelberg, Germany
[5] Heidelberg Univ Hosp, Dept Med Endocrinol & Clin Chem 1, Heidelberg, Germany
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.198
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1116P
引用
收藏
页码：S918 / S918
页数：1
相关论文
共 50 条
  • [21] Treatment response and clinical outcomes of well-differentiated high-grade neuroendocrine tumors to 177Lu-DOTATATE.
    Coffman, Kelley Lauren
    Bodei, Lisa
    Le, Tiffany
    Choi, Ye
    Chou, Joanne F.
    Capanu, Marinela
    Dunphy, Mark
    Fox, Josef J.
    Grewal, Ravinder K.
    Reddy, Ryan
    Riedl, Christopher
    Schoder, Heiko
    Reidy, Diane Lauren
    Raj, Nitya Prabhakar
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [22] Treatment Response and Clinical Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors to Lutetium-177-DOTATATE
    Raj, Nitya
    Coffman, Kelley
    Le, Tiffany
    Do, Richard Kinh Gian
    Rafailov, Johnathan
    Choi, Ye
    Chou, Joanne F.
    Capanu, Marinela
    Dunphy, Mark
    Fox, Josef J.
    Grewal, Ravinder K.
    Reddy, Ryan P.
    Riedl, Christopher
    Schoder, Heiko
    Bodei, Lisa
    Reidy-Lagunes, Diane
    NEUROENDOCRINOLOGY, 2022, 112 (12) : 1177 - 1186
  • [23] Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors
    Kotteas, Elias A.
    Syrigos, Konstantinos N.
    Saif, Muhammad Wasif
    ONCOTARGETS AND THERAPY, 2016, 9 : 699 - 704
  • [24] Treatment of localized well-differentiated rectal neuroendocrine tumors: A focused review
    Emoto, Shigenobu
    Nozawa, Hiroaki
    Sasaki, Kazuhito
    Murono, Koji
    Matsuzaki, Hiroyuki
    Yokoyama, Yuichiro
    Abe, Shinya
    Nagai, Yuzo
    Yoshioka, Yuichiro
    Shinagawa, Takahide
    Sonoda, Hirofumi
    Ishihara, Soichiro
    FORMOSAN JOURNAL OF SURGERY, 2023, 56 (03) : 73 - 79
  • [25] Well-differentiated neuroendocrine tumors of the digestive tract: Focus on pancreatic neuroendocrine tumors
    Pellat, Anna
    Barat, Maxime
    Cottereau, Anne-Segolene
    Terris, Benoit
    Coriat, Romain
    BULLETIN DU CANCER, 2023, 110 (09) : 955 - 967
  • [26] Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors
    Partelli, Stefano
    Landoni, Luca
    Andreasi, Valentina
    Nessi, Chiara
    Muffatti, Francesca
    Crippa, Stefano
    Cingarlini, Sara
    Bassi, Claudio
    Falconi, Massimo
    SURGERY, 2020, 168 (05) : 816 - 824
  • [27] Correlation Between mTOR Pathway and Clinical Outcomes in Patients with Well-Differentiated Neuroendocrine Tumors Treated with Everolimus
    Spada, F.
    Pisa, E.
    Lorizzo, K.
    Barberis, M.
    Fazio, N.
    NEUROENDOCRINOLOGY, 2012, 96 : 13 - 13
  • [28] Early Onset Well-Differentiated Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathologic Features, and Oncological Outcomes
    Pulvirenti, Alessandra
    Hauser, Haley
    Le, Tiffany
    McIntyre, Caitlin
    Reidy-Lagunes, Diane
    Wei, Alice
    Raj, Nitya
    PANCREAS, 2022, 51 (03) : E51 - E51
  • [29] Clinicopathologic features of well-differentiated lung neuroendocrine tumors
    Pakbaz, Sara
    Hodgson, Anjelica
    Asa, Sylvia
    Mete, Ozgur
    LABORATORY INVESTIGATION, 2019, 99
  • [30] The role of chemotherapy in well-differentiated GIT neuroendocrine tumors
    Ellaithy, A.
    El-Sakka, A. A.
    ANNALS OF ONCOLOGY, 2023, 34 : S142 - S142
12345